Long-Term NIH Grants Raise Doubts

WASHINGTON—Recent increases in the number and type of longterm grants from the National Institutes of Health may intensify competition between new awards and grants continued from previous years. But officials say the self-limiting nature of the new longterm grants and new institute controls should prevent problems that forced elimination of seven-year awards in the 1970s. “In any given year, about 85 percent of the NIH budget is a commitment [to grants] from previous years,”

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—Recent increases in the number and type of longterm grants from the National Institutes of Health may intensify competition between new awards and grants continued from previous years. But officials say the self-limiting nature of the new longterm grants and new institute controls should prevent problems that forced elimination of seven-year awards in the 1970s.

“In any given year, about 85 percent of the NIH budget is a commitment [to grants] from previous years,” noted Norman Mansfield, director of the NIH division of finance management. The balance between funding new grants and continuing support for grants in their third, fourth or fifth year is “a delicate tradeoff,” he said.

According to William Goldwater, director of NIH’s extramural programs management office, the White House Office of Management and Budget is concerned about a growing commitment for continuing grants. He said such concerns explain “why NIH is very discreet” in its small ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Ron Cowen

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours